← Leaderboards
Sharon G Adler
La Biomed Res Inst/ Harbor Ucla Med Ctr
$6,091,045
Attributed
$6,091,045
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $843.6K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,091,045 · 15
By mechanism
U01$2,260,420 · 1
R01$2,057,403 · 1
M01$1,301,993 · 12
R21$471,229 · 1
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Eli Ipp$4,045,857
Others in their field
Top investigators on “Diabetic Nephropathy”
- John M Lachin · George Washington University$140,240,809
- David M Nathan · Massachusetts Institute Of Technology$119,524,803
- Rose A Gubitosi-Klug · Case Western Reserve University$70,295,008
- S Michael Mauer · University Of Minnesota Twin Cities$31,116,991
- Billy Gerald Hudson · Vanderbilt University Medical Center$27,051,004
- Alessandro Doria · Joslin Diabetes Center$19,651,882
Research focus
Diabetic NephropathyClinical ResearchAfrican AmericanGenetic MarkersResearch PersonnelHuman SubjectHuman Genetic Material TagMexican AmericansGenotypePathologic ProcessDiabetes Mellitus GeneticsAmericanLinkage DisequilibriumsFamily GeneticsKidney DiseasesRacial /Ethnic DifferenceGenetic SusceptibilityEuropeanLinkage MappingCaucasian AmericanDiabetes MellitusFundingComputer Retrieval Of Information On Scientific Projects DatabaseGrant
Grant awards (30)
SNP HAPLOTYPING TO DETECT DIABETIC NEPHROPATHY RISK$164,028
M01 · FY2010 · RR · contact PI
THE SAFETY AND EFFICACY OF MINOCYCLINE AS AN ANTI-PROTEINURIC IN DIABETIC NEPHRO$3,685
M01 · FY2010 · RR · contact PI
SNP HAPLOTYPING TO DETECT DIABETIC NEPHROPATHY RISK$180,566
M01 · FY2009 · RR · contact PI
MEXICAN-AMERICAN ADMIXTURE MAPPING DEVELOPMENT AND APPLICATION TO NIDDM$10,239
M01 · FY2009 · RR · contact PI
SNP Haplotyping to Detect Diabetic Nephropathy Risk$481,931
R01 · FY2008 · DK · contact PI
SNP HAPLOTYPING TO DETECT DIABETIC NEPHROPATHY RISK$150,578
M01 · FY2008 · RR · contact PI
SNP Haplotyping to Detect Diabetic Nephropathy Risk$98,020
R01 · FY2008 · DK · contact PI
MEXICAN-AMERICAN ADMIXTURE MAPPING DEVELOPMENT AND APPLICATION TO NIDDM$21,199
M01 · FY2008 · RR · contact PI
SNP Haplotyping to Detect Diabetic Nephropathy Risk$481,755
R01 · FY2007 · DK · contact PI
Efficacy/mechanisms of curcumin in diabetic nephropathy$188,102
R21 · FY2007 · AT · contact PI
Efficacy/mechanisms of curcumin in diabetic nephropathy$62,913
R21 · FY2007 · AT · contact PI
SNP HAPLOTYPING TO DETECT DIABETIC NEPHROPATHY RISK$29,522
M01 · FY2007 · RR · contact PI
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$9,720
M01 · FY2007 · RR · contact PI
SNP Haplotyping to Detect Diabetic Nephropathy Risk$486,136
R01 · FY2006 · DK · contact PI
Efficacy/mechanisms of curcumin in diabetic nephropathy$220,214
R21 · FY2006 · AT · contact PI
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$97,330
M01 · FY2006 · RR · contact PI
A PHASE I STUDY OF FG-3019 IN SUBJECTS WITH TYPE I OR II DIABETES$39,891
M01 · FY2006 · RR · contact PI
SNP Haplotyping to Detect Diabetic Nephropathy Risk$509,561
R01 · FY2005 · DK
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$139,962
M01 · FY2005 · RR
Identification of Diabetic Nephropathy Risk Genes$216,313
M01 · FY2004 · RR
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$150,000
U01 · FY2004 · DK
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$80,000
U01 · FY2004 · DK
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$555,420
U01 · FY2003 · DK
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$50,000
U01 · FY2003 · DK
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$550,000
U01 · FY2002 · DK
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$425,000
U01 · FY2001 · DK
PATHOGENESIS OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I DIABETES MELLITUS$237,978
M01 · FY2001 · RR
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$25,000
U01 · FY2001 · DK
IDENTIFICATION OF DIABETIC NEPHROPATHY RISK GENES$425,000
U01 · FY2000 · DK
PATHOGENESIS OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I DIABETES MELLITUS$982
M01 · FY2000 · RR